HIV Diagnostics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Test (Antibody Tests, Viral Identification, CD4 Testing, Viral Load Testing, Others), By End-User (Hospitals, Diagnostic Centers, Blood Banks, Home Care Settings), and Region Forecast 2021-2032

HIV diagnostics market size was valued at US$ 4.5 billion in 2025 and is expected to reach US$ 7.9 billion by 2032, growing at a significant CAGR of 8.2% from 2026-2032. Acquired immune deficiency syndrome (AIDS) is a retroviral infectious disease caused by human immunodeficiency virus (HIV). HIV attacks the body immune system ideally CD4 cells (T cells), which helps the immune system to fight infections. HIV spreads through body fluids i.e. blood donation and imparting needles to somebody who is HIV infected, and sexual interactions. If HIV is not treated the opportunistic infections like tuberculosis or cancer take advantage of very weak immune system and causes AIDS. The market can be done by viral load test, saliva test, and blood test. Most accurate test results can obtained by enzyme linked immunosorbent assay (ELISA) test initial stages and western blot method on later stages.

Currently, there was no effective cure exists for HIV, but with proper medical care, it can be controlled. Global HIV diagnosis market is growing at steady state. Government and non-government organizations are also participating in creating and growing awareness related to early HIV diagnosis and available diagnostic tests and equipment. According to WHO, 2015, there is 0.8% prevalence of HIV globally and Sab-Saharan Africa remains most severely affected area with 70% of people for global population.

For instance, the unmet requirements in Asia and Africa region for HIV diagnosis, and the government initiatives taken in the region may drive the market for HIV diagnostics. Market players adopting mergers and acquisitions to increase the market position in the market. In addition, market has a number of pipeline products in accurate and quick diagnosis of HIV few of them are Visitect CD4, Chipcare CD4, and MBIO CD4. Antibody diagnosis test is predominant among the segments. Due to the introduction of point of care products can easily and quickly diagnose disease.

Key Market Trends & Insights

• North America dominated the HIV diagnostics market in 2024, driven by advanced diagnostic technologies and mandatory screening programs.
• Asia Pacific is projected to grow fastest due to rising HIV cases, improved awareness, and government initiatives.
• Key growth drivers include higher prevalence of HIV, expansion of point-of-care testing, and innovative diagnostics like rapid antigen and nanomechanical tests.
• WHO and industry collaborations are accelerating access to affordable, multi-disease testing kits worldwide.

Market Size & Forecast

• 2025 Market Size: US$ 4.5 Billion
• 2032 Projected Market Size: US$ 7.9 Billion
• CAGR (2025–2031): 8.2%
• Leading Region: North America

Key Developments

• In July 2025, the World Health Organization (WHO) prequalified the Determine™ Antenatal Care Panel, the first bundled set of three rapid diagnostic tests capable of simultaneously detecting HIV, hepatitis B virus (HBV), and syphilis. This prequalification aims to improve timely access to testing for pregnant women, supporting efforts to eliminate mother-to-child transmission of these infections as part of the global triple elimination initiative.
• In April 2025, a team of scientists at Northwestern University developed a rapid point-of-care HIV test using a nanomechanical platform with tiny silicon cantilevers to detect multiple HIV antigens in minutes. The technology, described in Biosensors and Bioelectronics, is cost-effective, easily mass-produced, and can be integrated into a solar-powered device, enabling fast HIV detection in remote areas without the need for traditional laboratory testing.